Related Experiment Video
Updated: Jan 30, 2026

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment
Giorgia Scarpellino1, Tullio Genova1,2, Luca Munaron1
1Department of Life Sciences and Systems Biology, University of Torino, Torino, Italy.
Background:
Purinergic signalling is involved in several physiological and pathophysiological processes. P2X7 Receptor (P2X7R) is a calcium-permeable ion channel that is gaining interest as a potential therapeutic target for the treatment of different diseases including inflammation, pain, psychiatric disorders and cancer. P2X7R is ubiquitously expressed and sensitive to high ATP levels, usually found in tumor microenvironment. P2X7R regulates several cell functions, from migration to cell death, but its selective contribution to tumor progression remains controversial.
Objective:
Current review was conducted to check involvement of P2X7R use in cancer treatment.
Methods:
We review the most recent patents focused on the use of P2X7R in the treatment of cancer.
Results:
P2X7R is an intriguing purinergic receptor that plays different roles in tumor progression.
Conclusion:
Powerful strategies able to selectively interfere with its expression and function should reveal helpful in the development of new anti-cancer therapies.
More Related Videos
11:47Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells
Published on: April 3, 2019
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
Related Concept Videos
The Tumor Microenvironment
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Internal Receptors
Cationic Chain-Growth Polymerization: Mechanism
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...